Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

April 12, 2000

Nasacort® AQ, Nasal Spray Recalled

Collegeville, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Aventis is recalling Nasacort® AQ, Nasal Spray because of super-potency (stability).

The recalled Nasacort® AQ, Nasal Spray (Triamcinolone acetonide-16.5 grams), 120 metered acutations, is a prescription for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older. (NDC #0075-1506-16.)

According to the FDA, approximately 46,000 units were distributed Nationwide and in Thailand.  The recalled product bears the Lot # MN3270 EXP 12/00.  The firm estimates none remains on the market.

This ongoing Class II recall was initiated by Aventis, by letter dated February 22, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-261-0

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.